FOXA1 and Patent ductus arteriosus: Furthermore, in metastatic pancreatic ductal adenocarcinoma (PDA), FOXA1 becomes enriched at novel enhancer sites, driving a developmental reprogramming of PDA cells characterized by a gene expression profile resembling that of the embryonic foregut endoderm [148].